Linda studies the geology of central Oregon
While killing
time prowling through the WiFi jungle in search of useful news about either
either/or ovarian cancer or the stock market, I stumbled upon an article which
may turn out to be a double whammy:
https://www.healtheuropa.eu/promise-for-ovarian-cancer-treatment-from-plant-derived-drug/107818/
Seems as
though some people in Kentucky have uncovered evidence that a drug called
artesunate – heretofore employed as a heavy duty weapon against advanced
malaria – may have genuine value against ovarian cancer as well. At least. In
vitro it looks likely. The authors of
this blurb suggest that it might be combined with carboplatin and paclitaxel as
a first-strike therapy. Probably not a
cure, but welcome nonetheless.
Warning: artesunate is derived from a member of the
very common Artemisia family. For heaven’s
sake, don’t just go out, pick some common
Artemisia plant and steam it for dinner.
Some are poisonous.
As for the
stock market potential – forgetaboutit!
No comments:
Post a Comment